1. Home
  2. RGC

RGC

Regencell Bioscience Holdings Limited

Logo Regencell Bioscience Holdings Limited

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-24-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Founded: 2014 Country:
Hong Kong
Hong Kong
Employees: N/A City: N/A
Market Cap: 83.8M IPO Year: 2021
Target Price: N/A AVG Volume (30 days): 4.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.45 EPS Growth: N/A
52 Week Low/High: $3.16 - $31.30 Next Earning Date: 06-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: